metricas
covid
Annals of Hepatology P1- HIGH VIRAL SUPPRESSION AND IMPROVED SAFETY PROFILE OF TENOFOVIR ALAFENAMIDE ...
Journal Information

Statistics

Follow this link to access the full text of the article

P1- HIGH VIRAL SUPPRESSION AND IMPROVED SAFETY PROFILE OF TENOFOVIR ALAFENAMIDE RELATIVE TO TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B PATIENTS TREATED FOR 5 YEARS
Wai Kay Seto1, Ting-Tsung Chang2, Abhijit Chowdhry3, Chi-Yi Chen4, Mustafa Kemal Celen5, Xiaoli Ma6, Mang Ma7, Ajay Duseja8, Ki Tae Yoon9, Wan Cheng Chow10, Leland Yee11, Gregor Weber11, Ms Jin Youn11, John F. Flaherty11, Anuj Gaggar11, Bing Gao11, Gregory Camus11, Eric Bassetti11, Jae Seok Hwang12, Tetshuro Inokuma13..., Young- Suk Lin14, Edward J. Gane15Ver más
1 The University of Hong Kong, Hong Kong, Hong Kong
2 National Cheng-Kung University Hospital, Tainan, Taiwan
3 Institute of Post Graduate Medical Education and Research, Kolkata, India
4 Chia-Yi Christian Hospital, Chia-Yi, Taiwan
5 Dicle U¨Niversitesi Hastanesi Enfeksiyon Hastaliklari Anabilim Dali, Diyarbakir, Turkey
6 Xiaoli Ma, P.C., Philadelphia, USA
7 Zeidler Ledcor Centre, Edmonton, Canada
8 Postgraduate Institute of Medical Education & Research, Chandigarh, India
9 Pusan National University Yangsan Hospital, Yangsan, Korea
10 Singapore General Hospital, Singapore, Singapore
11 Gilead Sciences Inc., Foster City, USA
12 Keimyung University Dongsan Medical Center, Daegu, Korea
13 Kobe City Medical Center General Hospital, Kobe, Japan
14 Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
15 Liver Unit University of Auckland, Grafton, New Zealand
Ver más
Read
742
Times
was read the article
207
Total PDF
535
Total HTML
Share statistics
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 28 4 32
2025 11 126 24 150
2025 10 24 11 35
2025 9 17 10 27
2025 8 23 24 47
2025 7 21 7 28
2025 6 11 5 16
2025 5 16 3 19
2025 4 18 9 27
2025 3 20 6 26
2025 2 26 3 29
2025 1 18 9 27
2024 12 18 4 22
2024 11 24 4 28
2024 10 11 2 13
2024 9 12 3 15
2024 8 22 7 29
2024 7 8 3 11
2024 6 13 3 16
2024 5 19 6 25
2024 4 9 4 13
2024 3 9 2 11
2024 2 7 7 14
2024 1 4 6 10
2023 12 1 4 5
2023 11 4 6 10
2023 10 7 9 16
2023 9 3 5 8
2023 8 2 4 6
2023 7 2 6 8
2023 6 1 3 4
2023 5 11 4 15
Show all

Follow this link to access the full text of the article